- Generic name
- Palonosetron
- Strength
- 500 mcg
- Dosage form
- Capsule
- Manufactured by
- Renata PLC.
Vomiren Soft Gel Capsule Capsule
About Vomiren Soft Gel Capsule 500 mcg
Vomiren Soft Gel Capsule is a 500 mcg palonosetron capsule from Renata PLC. It is an anti-emetic medicine used to help control nausea and vomiting in specific situations outlined below.
There are 16 brands of Palonosetron listed in Bangladesh.
What is Vomiren Soft Gel Capsule 500 mcg?
Vomiren Soft Gel Capsule contains palonosetron 500 mcg and belongs to a group of medicines called anti-emetics. It works by blocking certain receptors involved in the vomiting reflex. It is used for acute and delayed nausea and vomiting, including nausea and vomiting caused by chemotherapy or radiotherapy, and for uncontrolled nausea and vomiting. Because it is a prescription medicine, the doctor decides whether it is suitable and how it should be taken. Do not start, stop or change it without medical advice.
Uses of Vomiren Soft Gel Capsule
Vomiren Soft Gel Capsule is used to treat acute and delayed nausea and vomiting. It is also used for uncontrolled nausea and vomiting and for nausea and vomiting caused by chemotherapy or radiotherapy. It is an anti-emetic medicine, meaning it acts against nausea and vomiting. Only a doctor can decide if it is appropriate for a particular person and situation.
How to use Vomiren Soft Gel Capsule
Take Vomiren Soft Gel Capsule exactly as the doctor tells you. The doctor decides the dose, when to take it and how long the course should last, so follow the prescription and the pharmacist's instructions. Swallow the capsule as directed. If you are unsure how or when to take it, ask your doctor or pharmacist. Do not change the dose or stop it on your own.
Side effects of Vomiren Soft Gel Capsule
The most common side effects are headache and constipation. Tell your doctor if these bother you or do not settle. Ask your doctor or pharmacist about anything unusual you notice after taking Vomiren Soft Gel Capsule, and seek medical help promptly if you have a severe reaction or any symptom that worries you. Do not self-treat side effects without advice.
Safety and precautions
Vomiren Soft Gel Capsule should not be used by anyone who is hypersensitive to palonosetron or to any of its ingredients. It is classified as pregnancy category B, and it is not known whether palonosetron passes into breast milk. Tell the doctor if you are pregnant, planning a pregnancy or breastfeeding, and about any other medicines you take, including those bought without a prescription. Ask the doctor first if you have any health concerns or allergies.
Frequently asked questions
What is Vomiren Soft Gel Capsule used for and what kind of medicine is it?
It is an anti-emetic medicine containing palonosetron. It is used for acute and delayed nausea and vomiting, uncontrolled nausea and vomiting, and nausea and vomiting caused by chemotherapy or radiotherapy. The doctor decides if it is suitable for you.
What side effects should I watch for, and when should I call the doctor?
Headache and constipation are the most common side effects. Call your doctor if these are troublesome or do not settle, or if you notice any severe or worrying reaction. Do not treat side effects yourself without asking a doctor or pharmacist first.
How should I store Vomiren Soft Gel Capsule?
Keep it in a cool, dry place away from light. Store it out of the reach of children, and do not use it after the expiry date. If you are unsure about storage, ask your pharmacist.
Can I take Vomiren Soft Gel Capsule without a prescription?
No. It is an anti-emetic medicine that should be used only when a doctor has prescribed it. The doctor decides the dose and course. Do not start, stop or change it on your own, and tell the doctor about other medicines you take.
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Pharmacology
Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
Dosage & Administration
Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Overdose Effects
Storage Conditions
Alternative brands of Palonosetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.